Breakthrough telescope in Chile renamed for benefactor alum

The powerful new telescope being built for a high-elevation site in Chile by a consortium of U.S., German and Canadian academic institutions, led by Cornell, has a new name: the Fred Young Submillimeter Telescope.

Ezra

Engineered bacteria churn out cancer biomarkers

Researchers successfully engineered E. coli bacteria to produce O-linked glycoproteins – research that will illuminate the complex process of glycosylation and the role that protein-linked glycans play in health and disease.

Project to examine digital agriculture from many angles

Jaron Porciello in the Department of Global Development is exploring barriers to the widespread adoption of digital agriculture tools through a grant from USAID and the Bill & Melinda Gates Foundation.

Study shows difficulty in finding evidence of life on Mars

As scientists prepare to study Martian soil for signs of life, a new worry emerges. Acidic fluids once on Mars’ surface may have destroyed biological evidence hidden within the planet’s iron-rich clays.

Biopesticide startup gets $750K more in NSF funding

Ascribe Bioscience, a Cornell-based startup and UNY I-Corps alumni, has won a $750,000 National Science Foundation Small Business Innovation Research Phase II award.

Facebook anniversaries inspire reflection, nostalgia

Facebook posts about birthdays and anniversaries prompt users to reflect on the passage of time and the patterns of their lives, according to new Cornell research.

Pillemer: Family estrangement a problem ‘hiding in plain sight’

A new book by Karl Pillemer highlights the prevalence of family estrangement and offers tips for seeking reconciliation.

Mobile phone-based saliva test wins NIH prize

Cornell researchers’ concept for a mobile phone-based system to detect infectious diseases and nutritional deficiencies in saliva was awarded a $100,000 NIH Technology Accelerator Challenge prize.

Veterinary college team IDs gene that drives ovarian cancer

Scientists at the College of Veterinary Medicine have published a study that pinpoints which specific genes drive or delay high-grade serious ovarian carcinoma, the fifth-leading cause of cancer-related deaths in U.S. women.